2 Dividend Stocks Crushing the Market in 2026 (and Which Ones Can Keep Going)

Key PointsJohnson & Johnson’s medtech business is experiencing turbulence, but the company has what it takes to overcome it.

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nasdaq.com)